Non-Thermal Plasma is an extraordinary technology: it demonstrates its effectiveness in many areas of application, in the face of a low energy and environmental impact and this new study, conducted by the Department of Molecular Medicine of the University of Padua directed by Prof. Andrea Crisanti, is further proof!

The good or better excellent news on the health and prevention front is that Jonix Non-Thermal Plasma Technology has an effective bactericidal action on multi-resistant, pathogenic bacteria present in hospital environments, which is very dangerous because, as their name suggests, they are resistant to many types of antibiotics.

What are multidrug-resistant bacteria?

Infections caused by drug-resistant bacteria, particularly infections that are simultaneously resistant to several types of antibiotics, pose a significant threat to global public health. 

It is therefore important to find an effective and usable method in the presence of people, which can help contain these types of infections (MDR bacteria – MultiDrug Resistant).

In fact, multiresistant bacteria present different resistance mechanisms, such as to making at least 4 antibiotic families ineffective at the same time. These microorganisms can also be present in vulnerable areas such as operating theaters and intensive care units, where they can infect and aggravate the conditions of patients who are already in critical condition. Having a system that can constantly neutralize these bacteria from the air and surfaces, so that they do not spread in hospital environments, furthermore, without having contraindications for patients, is of enormous importance.

Effectiveness of Jonix Cube 

The study from the Department of Molecular Medicine worked on 4 species of bacteria (Escherichia Coli strain ATCC 10536, and 3 MDR, Acinetobacter baumanii, Klebsiella pneumoniae and Pseudomonas aeruginosa). The results obtained are positive: from only 12 hours, Jonix Non-Thermal Plasma Technology has a bactericidal effect on E. coli and K. pneumoniae, while for A. baumannii and P. aeruginosa, the effect is maximized after 16 hours of exposure.

This, therefore, shows us that the Jonix Cube device has an effective bactericidal activity on various multiresistant organisms after an exposure phase that can vary according to the organism studied.

Source – Infectious diseases and antimicrobial resistance (Italian Ministry of Health)